Atrial Fibrillation and Risk of ESRD in Adults with CKD

Nisha Bansal1, Dawei Xie, Kelvin Tao

  • 1Due to the number of contributing authors, the affiliations are provided in the Supplemental Material .

Insights

New-onset atrial fibrillation significantly increases the risk of end-stage renal disease (ESRD) in patients with chronic kidney disease (CKD). This finding highlights the importance of managing atrial fibrillation in CKD patients.

Area of Science:

  • Nephrology
  • Cardiology
  • Epidemiology

Background:

  • Atrial fibrillation is a common complication in patients with chronic kidney disease (CKD).
  • The association between atrial fibrillation and the progression to end-stage renal disease (ESRD) in CKD patients requires further elucidation.
  • This study investigates the link between new-onset atrial fibrillation and the risk of ESRD in individuals with CKD.

Purpose of the Study:

  • To examine the association between incident atrial fibrillation and the risk of developing ESRD in a cohort of patients with CKD.
  • To provide insights into the cardiovascular and renal outcomes in patients with comorbid CKD and atrial fibrillation.

Main Methods:

  • Analysis of participants from the prospective Chronic Renal Insufficiency Cohort Study without atrial fibrillation at baseline.
  • Incident atrial fibrillation identified via ECGs, self-report, and diagnostic codes, confirmed by adjudication.
  • ESRD ascertained through self-report, medical records, and US Renal Data System linkage.
  • Marginal structural models used to adjust for time-dependent confounders.

Main Results:

  • Among 3091 participants, 172 (5.6%) developed incident atrial fibrillation.
  • Incident atrial fibrillation was associated with a 3.2-fold higher rate of ESRD (95% CI, 1.9 to 5.2).
  • The association remained consistent across subgroups based on age, sex, race, diabetes, and baseline eGFR.

Conclusions:

  • Incident atrial fibrillation is linked to an elevated risk of ESRD in patients with CKD.
  • Further research is needed to identify modifiable pathways contributing to this increased risk.
  • Aggressive monitoring and treatment for atrial fibrillation in CKD patients may improve outcomes.
Abstract

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
595
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.0K
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
296
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
459
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
1.1K
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
548